R Roche
Updates & Highlights
simplywall.st · 5 days ago
Roche–Nurix Bexobrutideg Alliance Might Change The Case For Investing In Nurix Therapeutics (NRIX)
Cache Valley Daily · 5 days ago
Richard Thomas Roche
RAPS.org · 5 days ago
Recon: Biogen to acquire RayThera for $1B; FDA approves first generic version Roche flu drug
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Parental Leave
Family-friendly policies
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Roche?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentRoche–Nurix Bexobrutideg Alliance Might Change The Case For Investing In Nurix Therapeutics (NRIX)
Roche–Nurix Bexobrutideg Alliance Might Change The Case For Investing In Nurix Therapeutics (NRIX)
simplywall.st · 5 days ago
Richard Thomas Roche
Richard Thomas Roche
Cache Valley Daily · 5 days ago
Recon: Biogen to acquire RayThera for $1B; FDA approves first generic version Roche flu drug
Recon: Biogen to acquire RayThera for $1B; FDA approves first generic version Roche flu drug
RAPS.org · 5 days ago
FDA Accepts Roche's Application for Lunsumio and Polivy Combination in Relapsed or Refractory Large B-Cell Lymphoma
FDA Accepts Roche's Application for Lunsumio and Polivy Combination in Relapsed or Refractory Large B-Cell Lymphoma
BioPharm International · 5 days ago
FDA Accepts Roche's Filing for Lunsumio VELO-Polivy in LBCL
FDA Accepts Roche's Filing for Lunsumio VELO-Polivy in LBCL
TradingView · 5 days ago
FDA approves first generic of Roche's flu drug Xofluza
FDA approves first generic of Roche's flu drug Xofluza
pharmaphorum · 5 days ago
FDA accepts Roche’s sBLA for Lunsumio and Polivy combo
FDA accepts Roche’s sBLA for Lunsumio and Polivy combo
The Pharma Letter · 5 days ago
Roche faces first FDA-approved generic targeting flu drug, Xofluza
Roche faces first FDA-approved generic targeting flu drug, Xofluza
Seeking Alpha · 5 days ago
Roche lymphoma drug gets FDA review for label expansion (RHHBY)
Roche lymphoma drug gets FDA review for label expansion (RHHBY)
Seeking Alpha · 5 days ago
Roche’s outpatient-ready lymphoma combo clears FDA filing review
Roche’s outpatient-ready lymphoma combo clears FDA filing review
Stock Titan · 6 days ago
FDA approves first generic version of Roche's flu drug
FDA approves first generic version of Roche's flu drug
Reuters · 6 days ago
The Latest Beauty Executive Moves at Sephora, La Roche-Posay and More
The Latest Beauty Executive Moves at Sephora, La Roche-Posay and More
WWD · 6 days ago
Physician Views Preview: How quickly will oncologists adopt Roche's giredestrant in early-stage breast cancer?
Physician Views Preview: How quickly will oncologists adopt Roche's giredestrant in early-stage breast cancer?
FirstWord Pharma · 7 days ago
EHA26: AstraZeneca battles Roche in untreated follicular lymphoma
EHA26: AstraZeneca battles Roche in untreated follicular lymphoma
Yahoo Finance · 8 days ago
EHA26: AstraZeneca battles Roche in untreated follicular lymphoma
EHA26: AstraZeneca battles Roche in untreated follicular lymphoma
Clinical Trials Arena · 8 days ago
AZ's Truqap and Roche assay cleared for PTEN prostate cancer
AZ's Truqap and Roche assay cleared for PTEN prostate cancer
pharmaphorum · 9 days ago
Roche Oncology Milestones Spark Fresh Look At Valuation And Growth Potential
Roche Oncology Milestones Spark Fresh Look At Valuation And Growth Potential
Yahoo Finance · 11 days ago
AstraZeneca's AKT inhibitor, Roche's CDx, cleared in US for prostate cancer biomarker strategy
AstraZeneca's AKT inhibitor, Roche's CDx, cleared in US for prostate cancer biomarker strategy
FirstWord Pharma · 11 days ago
Roche and Nestlé fear talent crunch as Switzerland puts population cap to the polls
Roche and Nestlé fear talent crunch as Switzerland puts population cap to the polls
Fortune · 11 days ago
Richard Thomas Roche Obituary Jun 12, 2026
Richard Thomas Roche Obituary Jun 12, 2026
Rudd Funeral Home · 12 days ago